Trial Profile
A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group, Phase 1 Study to Compare the Tolerability of OROS Paliperidone (Extended Release) With Immediate-Release (IR) Risperidone in Subjects With Schizophrenia.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Apr 2010
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary) ; Risperidone
- Indications Schizophrenia
- Focus Adverse reactions
- Sponsors Janssen Research & Development
- 28 Nov 2008 New trial record.